A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal-Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes.
Sultan LinjawiByung-Wan LeeÖmür TabakSusanna LövdahlShanti WertherSalahedeen AbusnanaPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)
ClinicalTrials.gov identifier, NCT02453685.